{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:00:27Z","timestamp":1770292827372,"version":"3.49.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Several clinical trials have shown that immunotherapy plays a pivotal role in the treatment of patients with metastatic synovial sarcoma. Immune-related genes (IRGs) have been demonstrated to predict the immunotherapy response in certain malignant tumours. However, the clinical significance of IRGs in patients with synovial sarcoma (SS) is still unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We first combined the immune-related ImmPort gene set to search for SS related to metastatic and differentially expressed immune-related genes (DEIRGs) in the GSE40021 dataset from the GEO database. The soft tissue sarcoma database in TCGA was used for univariate Cox regression analyses to identify DEIRGs that were related to overall survival and to build an immune-related prognostic assessment model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study screened a total of six DEIRGs that were closely related to prognosis in metastatic SS. Further analysis showed that there was no significant difference in the expression of several immune checkpoints between the two groups in the GSE40021 data. Moreover, the GREM2 and CTSS genes were significantly expressed in metastatic patients. Further verification of clinical SS tissues from our centre by RT-qPCR analysis demonstrated reduced infiltration of activated NK cells and macrophages but increased M2-type macrophages in metastatic patients. Together, our study successfully constructed an immune-related prognostic assessment model and probably explains the poor efficacy of PD-1 inhibitors for SS patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The research deepens our understanding of the tumor immune microenvironment and proposes a new immune mechanism for metastatic SS. Early intervention and reversal of immunosuppressive microenvironmental changes are expected to delay metastasis and improve survival.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1448464","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T06:35:08Z","timestamp":1733812508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of a novel immune-related prognostic model and the potential metastatic mechanism in synovial sarcoma"],"prefix":"10.3389","volume":"15","author":[{"given":"Yufeng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuangzhong","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huixiong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaiyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/PAP.0000000000000284","article-title":"The 2020 WHO classification of tumors of soft tissue: selected changes and new entities","volume":"28","author":"Choi","year":"2021","journal-title":"Adv Anat Pathol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v101:3","article-title":"Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution","volume":"101","author":"Ferrari","year":"2004","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1201","article-title":"Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for survival","volume":"14","author":"Singer","year":"1996","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.138203","article-title":"Primary synovial sarcoma of the maxilla","volume":"10","author":"Aparna","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jso.20974","article-title":"Diagnosis and management of synovial sarcoma","volume":"97","author":"Eilber","year":"2008","journal-title":"J Surg Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30624-1","article-title":"Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial","volume":"18","author":"Tawbi","year":"2017","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30006-8","article-title":"Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials","volume":"19","author":"D'Angelo","year":"2018","journal-title":"Lancet Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-17-1417","article-title":"Antitumor activity associated with prolonged persistence of adoptively transferred NY-ESO-1 (c259)T cells in synovial sarcoma","volume":"8","author":"D'Angelo","year":"2018","journal-title":"Cancer Discovery"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-014-8516-1","article-title":"ImmPort: disseminating data to the public for the future of immunology","volume":"58","author":"Bhattacharya","year":"2014","journal-title":"Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkj021","article-title":"The gene ontology (GO) project in 2006","volume":"34","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.014","article-title":"Comprehensive and integrated genomic characterization of adult soft tissue sarcomas","volume":"171","year":"2017","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41467-020-20603-4","article-title":"Sarcoma classification by DNA methylation profiling","volume":"12","author":"Koelsche","year":"2021","journal-title":"Nat Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-0288-4","article-title":"The epigenomics of sarcoma","volume":"20","author":"Nacev","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1038\/s41467-022-30447-9","article-title":"Phase transition and remodeling complex assembly are important for SS18-SSX oncogenic activity in synovial sarcomas","volume":"13","author":"Cheng","year":"2022","journal-title":"Nat Commun"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3868","article-title":"Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor","volume":"18","author":"Maj","year":"2017","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1317420","article-title":"IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils","volume":"6","author":"Lucarini","year":"2017","journal-title":"Oncoimmunology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1038\/s41467-020-20140-0","article-title":"Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages","volume":"11","author":"Song","year":"2020","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00319-2","article-title":"Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial","volume":"403","author":"D'Angelo","year":"2024","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02128-z","article-title":"Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial","volume":"29","author":"Hong","year":"2023","journal-title":"Nat Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00392-8","article-title":"Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial","volume":"23","author":"Somaiah","year":"2022","journal-title":"Lancet Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00411-2","article-title":"T cells for advanced synovial sarcoma or myxoid round cell liposarcoma","volume":"403","author":"Schlegel","year":"2024","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.18632\/aging.104017","article-title":"Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients","volume":"12","author":"Li","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00790","article-title":"The construction of bone metastasis-specific prognostic model and co-expressed network of alternative splicing in breast cancer","volume":"8","author":"Huang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2020.05.008","article-title":"Harnessing natural killer immunity in metastatic SCLC","volume":"15","author":"Best","year":"2020","journal-title":"J Thorac Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1038\/s41467-020-18125-0","article-title":"Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molcel.2019.10.023","article-title":"Cancer-derived succinate promotes macrophage polarization and cancer metastasis via succinate receptor","volume":"77","author":"Wu","year":"2020","journal-title":"Mol Cell"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12943-016-0551-1","article-title":"Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis","volume":"15","author":"Marshall","year":"2016","journal-title":"Mol Cancer"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1038\/s41467-022-30453-x","article-title":"Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets","volume":"13","author":"Nacev","year":"2022","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/14728222.2024.2306344","article-title":"Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets","volume":"28","author":"Merlini","year":"2024","journal-title":"Expert Opin Ther Targets"},{"key":"B33","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s13046-021-02150-y","article-title":"Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcoma","volume":"40","author":"Lanzi","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5296","DOI":"10.1038\/s41467-022-32491-x","article-title":"Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma","volume":"13","author":"Gyurdieva","year":"2022","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"101618","DOI":"10.1016\/j.esmoop.2023.101618","article-title":"Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies","volume":"8","author":"Blay","year":"2023","journal-title":"ESMO Open"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.04.011","article-title":"The CD47-SIRP\u03b1 Immune checkpoint","volume":"52","author":"Logtenberg","year":"2020","journal-title":"Immunity"},{"key":"B37","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1038\/s41467-020-18245-7","article-title":"Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells","volume":"11","author":"Candas-Green","year":"2020","journal-title":"Nat Commun"},{"key":"B38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12967-020-02512-8","article-title":"Comprehensive profiling of immune-related genes in soft tissue sarcoma patients","volume":"18","author":"Hu","year":"2020","journal-title":"J Transl Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1448464\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T09:40:51Z","timestamp":1734082851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1448464\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2024.1448464"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1448464","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"article-number":"1448464"}}